gip glp-1 dual agonist Comparison between RA and the GLP-1/GIP Mechanisms of action and effects

The physiologically active form of the medium-chain acylcarnitine octanoyl-L-carnitine is a marker of medium-chain acetyl-CoA dehydrogenase deficiency, and is also a marker in the ratios of -ketothiolase deficiency, holocarboxylase synthesis, biotinidase, and glutaric acidemia

When all that goes haywire, your skin can get dry and itchy

Now a Danish study confirms that this drug may help reduce problem drinking ( The Lancet , May 2, 2026)

Sikiri's group were so struck by it that they proposed it might be the first of an entirely new class of medicines "a useful prototype of a new class of drugs," which they called organoprotective agents [9]